MARKET

ADIL

ADIL

Adial Pharmaceuticals Inc
NASDAQ
1.380
-0.060
-4.17%
Closed 19:49 05/13 EDT
OPEN
1.370
PREV CLOSE
1.380
HIGH
1.440
LOW
1.361
VOLUME
55.83K
TURNOVER
0
52 WEEK HIGH
18.90
52 WEEK LOW
1.354
MARKET CAP
2.96M
P/E (TTM)
-0.1157
1D
5D
1M
3M
1Y
5Y
1D
Adial Pharmaceuticals: Buy Rating Reiterated as AD04’s Precision AUD Strategy Advances; $8 Price Target Maintained
TipRanks · 16h ago
Adial Pharmaceuticals Q1 net loss narrows on lower R&D spending
Reuters · 2d ago
Adial Pharmaceuticals reports Q1 results
Seeking Alpha · 2d ago
*Adial Pharmaceuticals: Runway to Fund Operating Expenses Into 2nd Half of 2026 >ADIL
Dow Jones · 2d ago
*Adial Pharmaceuticals 1Q Loss $2M >ADIL
Dow Jones · 2d ago
ADIAL PHARMACEUTICALS REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Reuters · 2d ago
ADIAL PHARMACEUTICALS Q1 NET INCOME USD -2 MILLION
Reuters · 2d ago
Press Release: Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update
Dow Jones · 2d ago
More
About ADIL
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of therapies for the treatment and prevention of addiction and related disorders. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients and was recently investigated in the Company’s ONWARD pivotal Phase III clinical trial for the potential treatment of AUD in subjects with certain target genotypes identified using the Company’s proprietary companion diagnostic genetic test. AD04 is also used for the treatment of other addictive disorders, such as Opioid Use Disorder, obesity, smoking, and other drug addictions. The Company’s wholly owned subsidiary is Purnovate, Inc.

Webull offers Adial Pharmaceuticals Inc stock information, including NASDAQ: ADIL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADIL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADIL stock methods without spending real money on the virtual paper trading platform.